![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NHP2 |
Gene summary for NHP2 |
![]() |
Gene information | Species | Human | Gene symbol | NHP2 | Gene ID | 55651 |
Gene name | NHP2 ribonucleoprotein | |
Gene Alias | DKCB2 | |
Cytomap | 5q35.3 | |
Gene Type | protein-coding | GO ID | GO:0000154 | UniProtAcc | J3QSY4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55651 | NHP2 | GSM4909281 | Human | Breast | IDC | 4.89e-04 | 3.15e-01 | 0.21 |
55651 | NHP2 | GSM4909286 | Human | Breast | IDC | 2.63e-03 | -1.26e-02 | 0.1081 |
55651 | NHP2 | GSM4909293 | Human | Breast | IDC | 3.77e-05 | 2.79e-01 | 0.1581 |
55651 | NHP2 | GSM4909294 | Human | Breast | IDC | 4.85e-05 | 2.74e-02 | 0.2022 |
55651 | NHP2 | GSM4909296 | Human | Breast | IDC | 3.92e-21 | 3.20e-01 | 0.1524 |
55651 | NHP2 | GSM4909297 | Human | Breast | IDC | 5.39e-19 | -1.58e-02 | 0.1517 |
55651 | NHP2 | GSM4909298 | Human | Breast | IDC | 4.40e-22 | 5.33e-01 | 0.1551 |
55651 | NHP2 | GSM4909301 | Human | Breast | IDC | 1.45e-30 | 5.64e-01 | 0.1577 |
55651 | NHP2 | GSM4909304 | Human | Breast | IDC | 4.21e-12 | 4.66e-01 | 0.1636 |
55651 | NHP2 | GSM4909306 | Human | Breast | IDC | 7.95e-12 | 4.00e-01 | 0.1564 |
55651 | NHP2 | GSM4909307 | Human | Breast | IDC | 1.75e-19 | 5.12e-01 | 0.1569 |
55651 | NHP2 | GSM4909308 | Human | Breast | IDC | 2.01e-20 | 5.24e-01 | 0.158 |
55651 | NHP2 | GSM4909309 | Human | Breast | IDC | 6.19e-05 | 1.94e-01 | 0.0483 |
55651 | NHP2 | GSM4909311 | Human | Breast | IDC | 3.36e-48 | 2.87e-02 | 0.1534 |
55651 | NHP2 | GSM4909312 | Human | Breast | IDC | 1.46e-13 | 1.67e-01 | 0.1552 |
55651 | NHP2 | GSM4909316 | Human | Breast | IDC | 2.44e-03 | 1.95e-01 | 0.21 |
55651 | NHP2 | GSM4909317 | Human | Breast | IDC | 3.47e-05 | 3.19e-01 | 0.1355 |
55651 | NHP2 | GSM4909318 | Human | Breast | IDC | 2.86e-08 | 5.13e-01 | 0.2031 |
55651 | NHP2 | GSM4909319 | Human | Breast | IDC | 7.31e-61 | 2.31e-02 | 0.1563 |
55651 | NHP2 | GSM4909320 | Human | Breast | IDC | 1.39e-22 | 5.97e-01 | 0.1575 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004227326 | Esophagus | HGIN | ribosomal large subunit biogenesis | 34/2587 | 72/18723 | 8.82e-12 | 1.06e-09 | 34 |
GO:001607219 | Esophagus | HGIN | rRNA metabolic process | 72/2587 | 236/18723 | 2.26e-11 | 2.56e-09 | 72 |
GO:000636419 | Esophagus | HGIN | rRNA processing | 69/2587 | 225/18723 | 4.53e-11 | 5.04e-09 | 69 |
GO:003447010 | Esophagus | HGIN | ncRNA processing | 97/2587 | 395/18723 | 5.92e-09 | 3.90e-07 | 97 |
GO:00346606 | Esophagus | HGIN | ncRNA metabolic process | 104/2587 | 485/18723 | 2.26e-06 | 8.23e-05 | 104 |
GO:000072318 | Esophagus | HGIN | telomere maintenance | 38/2587 | 131/18723 | 4.38e-06 | 1.42e-04 | 38 |
GO:19048747 | Esophagus | HGIN | positive regulation of telomerase RNA localization to Cajal body | 9/2587 | 15/18723 | 4.11e-05 | 1.01e-03 | 9 |
GO:007189710 | Esophagus | HGIN | DNA biosynthetic process | 44/2587 | 180/18723 | 8.97e-05 | 1.96e-03 | 44 |
GO:19048727 | Esophagus | HGIN | regulation of telomerase RNA localization to Cajal body | 9/2587 | 18/18723 | 2.70e-04 | 4.67e-03 | 9 |
GO:000700417 | Esophagus | HGIN | telomere maintenance via telomerase | 21/2587 | 69/18723 | 2.80e-04 | 4.80e-03 | 21 |
GO:00322007 | Esophagus | HGIN | telomere organization | 38/2587 | 159/18723 | 4.23e-04 | 6.39e-03 | 38 |
GO:00906707 | Esophagus | HGIN | RNA localization to Cajal body | 9/2587 | 19/18723 | 4.50e-04 | 6.62e-03 | 9 |
GO:00906717 | Esophagus | HGIN | telomerase RNA localization to Cajal body | 9/2587 | 19/18723 | 4.50e-04 | 6.62e-03 | 9 |
GO:00906727 | Esophagus | HGIN | telomerase RNA localization | 9/2587 | 19/18723 | 4.50e-04 | 6.62e-03 | 9 |
GO:00906857 | Esophagus | HGIN | RNA localization to nucleus | 9/2587 | 19/18723 | 4.50e-04 | 6.62e-03 | 9 |
GO:001083318 | Esophagus | HGIN | telomere maintenance via telomere lengthening | 23/2587 | 81/18723 | 4.52e-04 | 6.62e-03 | 23 |
GO:000627810 | Esophagus | HGIN | RNA-dependent DNA biosynthetic process | 21/2587 | 75/18723 | 9.58e-04 | 1.21e-02 | 21 |
GO:00004707 | Esophagus | HGIN | maturation of LSU-rRNA | 10/2587 | 28/18723 | 3.04e-03 | 2.88e-02 | 10 |
GO:0022613111 | Esophagus | ESCC | ribonucleoprotein complex biogenesis | 365/8552 | 463/18723 | 1.74e-49 | 1.11e-45 | 365 |
GO:0042254111 | Esophagus | ESCC | ribosome biogenesis | 252/8552 | 299/18723 | 3.27e-44 | 1.04e-40 | 252 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NHP2 | deletion | Frame_Shift_Del | novel | c.99delN | p.Ile34SerfsTer22 | p.I34Sfs*22 | Q9NX24 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
NHP2 | SNV | Missense_Mutation | c.235A>G | p.Met79Val | p.M79V | Q9NX24 | protein_coding | tolerated(1) | benign(0) | TCGA-F4-6570-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NHP2 | SNV | Missense_Mutation | c.418N>A | p.Asp140Asn | p.D140N | Q9NX24 | protein_coding | tolerated(0.11) | benign(0.007) | TCGA-CI-6619-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
NHP2 | SNV | Missense_Mutation | c.242N>C | p.Leu81Ser | p.L81S | Q9NX24 | protein_coding | deleterious(0) | possibly_damaging(0.773) | TCGA-B5-A11G-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NHP2 | SNV | Missense_Mutation | rs752392516 | c.364N>T | p.Arg122Cys | p.R122C | Q9NX24 | protein_coding | deleterious(0) | probably_damaging(0.931) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
NHP2 | SNV | Missense_Mutation | novel | c.404N>G | p.Tyr135Cys | p.Y135C | Q9NX24 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
NHP2 | SNV | Missense_Mutation | novel | c.43G>T | p.Ala15Ser | p.A15S | Q9NX24 | protein_coding | tolerated(0.51) | benign(0.018) | TCGA-FI-A2F4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NHP2 | SNV | Missense_Mutation | c.177G>C | p.Gln59His | p.Q59H | Q9NX24 | protein_coding | tolerated(0.41) | possibly_damaging(0.77) | TCGA-55-6979-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | PD | |
NHP2 | SNV | Missense_Mutation | c.418N>A | p.Asp140Asn | p.D140N | Q9NX24 | protein_coding | tolerated(0.11) | benign(0.007) | TCGA-L9-A8F4-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
NHP2 | SNV | Missense_Mutation | novel | c.259C>G | p.Pro87Ala | p.P87A | Q9NX24 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-34-2609-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | gemcitabine | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |